FDA launch­es new dig­i­tal health ad­comm to tack­le in­com­ing com­plex­i­ties

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign-up, just click here.)

The FDA on Wednes­day launched a new ad­vi­so­ry com­mit­tee to re­view what will like­ly be an in­flux of new is­sues sur­round­ing nov­el health tech that’s grow­ing in­creas­ing­ly com­plex.

Like oth­er FDA ad­comms, the new Dig­i­tal Health Ad­vi­so­ry Com­mit­tee will fo­cus its at­ten­tion on these com­plex sci­en­tif­ic and tech­ni­cal is­sues. In this case, those is­sues will be re­lat­ed to dig­i­tal health tech­nolo­gies, which have his­tor­i­cal­ly ranged from un­reg­u­lat­ed mo­bile health apps to high­ly reg­u­lat­ed soft­ware that can help with clin­i­cal de­ci­sion-mak­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER